Retatrutide, Testosterone, and Weight Loss
Significant weight loss — which retatrutide produces — is associated with increases in testosterone in men with obesity-related hypogonadism. This is a physiological effect of fat loss, not a direct pharmacological effect of retatrutide on testosterone. No direct retatrutide-testosterone interaction data exists.
Weight Loss and Testosterone: The Established Relationship
Obesity is associated with lower testosterone levels in men, primarily through increased aromatization of testosterone to estrogen in adipose tissue and suppression of the hypothalamic-pituitary-gonadal axis. Significant weight loss is associated with increases in testosterone in men with obesity-related hypogonadism. This relationship is well-established from bariatric surgery and lifestyle intervention studies.
Does Retatrutide Directly Affect Testosterone?
No published data directly characterizes retatrutide's effect on testosterone levels. Any testosterone changes during retatrutide treatment are likely attributable to weight loss rather than direct pharmacological effects on the HPG axis. This has not been specifically studied.
Note on Retatrutide + Testosterone as a Stack
This page covers the physiological relationship between retatrutide-induced weight loss and testosterone levels. For information about combining retatrutide with exogenous testosterone (TRT) as a body composition stack, see the Retatrutide + Testosterone evidence review.
Questions about retatrutide? A licensed physician can review your case.
Start Physician Review